Riggs Asset Managment Co. Inc. Bluebird Bio, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $359 Million
- Q4 2024
A detailed history of Riggs Asset Managment Co. Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 350 shares of BLUE stock, worth $2,492. This represents 0.0% of its overall portfolio holdings.
Number of Shares
350
Previous 7,000
95.0%
Holding current value
$2,492
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BLUE
# of Institutions
19Shares Held
20.3MCall Options Held
0Put Options Held
2K-
Black Rock Inc. New York, NY15.4MShares$110 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$33.2 Million0.02% of portfolio
-
Colony Group LLC Boston, MA41.9KShares$298,6270.0% of portfolio
-
Connacht Asset Management LP New York, NY31.6KShares$225,2340.59% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL28.7KShares$204,4150.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $549M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...